Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer

Background: The incidence of colorectal cancer (CRC) in individuals of fertile age is increasing. Oxaliplatin is a cornerstone treatment in the adjuvant setting for stage III and high-risk stage II CRC. Limited data exist on possible side effects of oxaliplatin on fertility and gonadal function. Mor...

Full description

Bibliographic Details
Main Authors: Philip Falk, Mira Severin, Åke Berglund, Marianne G. Guren, Eva Hofsli, Pia Österlund, Anne Tandberg, Jakob Eberhard, Halfdan Sorbye
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000090